UK experts reject screening for ovarian cancer and osteoporosis
This article was originally published in Clinica
An expert group drawing up new UK national health service guidelines for the prevention and management of osteoporosis has rejected the idea of a national screening programme for the disease. It says health authorities should develop local strategies based on the new guidelines.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.